Synapse - Works

Results (4808)

Delays in intensification are common in adults with acute lymphoblastic leukemia (ALL), are associated with decreased survival in allogeneic hematopoietic cell transplant (HCT) patients

Meeting Abstract

Kumar, A.; Gimotty, P.; Gelfand, J.; Buck, G.; Rowe, J.; Goldstone, A.; Fielding, A.; Marks, D.; Litzow, M.; Paietta, E.; more...
Clinical Lymphoma, Myeloma and Leukemia (2015)

Fulltext@MSK | Save

Therapeutic activity of a bi-specific T cell engaging, TCR-mimic monoclonal antibody to WT1 against human leukemias and cancers in mouse models

Meeting Abstract

Pankov, D.; Dao, T.; Dubrovsky, L.
Clinical Lymphoma, Myeloma and Leukemia (2015)

Fulltext@MSK | Save

Very high dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia in the setting of intensified anthracycline induction and post stem-cell transplantation

Meeting Abstract

Itchaki, G.; Wolach, O.; Bar-Natan, M.; Yeshurun, M.; Ram, R.; Herscovici, C.; Douer, D.; Tallman, M.; Shpilberg, O.; Raanani, P.
Clinical Lymphoma, Myeloma and Leukemia (2015)

Fulltext@MSK | Save

Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed chronic lymphocytic leukemia

Meeting Abstract

Pagel, J. M.; Coutre, S. E.; Furman, R. R.; Sharman, J. P.; Cheson, B. D.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
Clinical Lymphoma, Myeloma and Leukemia (2015)

Fulltext@MSK | Save

Prognostic significance of survivin expression in patients with diffuse large B-cell lymphoma treated with R-CHOP therapy: A report from the International DLBCL Rituximab-CHOP Consortium Program

Meeting Abstract

Liu, Z. Y.; Xu-Monette, Z. Y.; Cao, X.; Visco, C.; Tzankov, A.; Montes-Moreno, S.; Dybkaer, K.; Chiu, A.; Orazi, A.; Zu, Y. L.; more...
Clinical Lymphoma, Myeloma and Leukemia (2015)

Fulltext@MSK | Save

Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: A report from The International DLBCL Rituximab-CHOP Consortium Program

Meeting Abstract

Shen, Q.; Xu-Monette, Z. Y.; Manyam, G. C.; Visco, C.; Tzankov, A.; Cao, X.; Deng, L. J.; Montes-Moreno, S.; Dybkaer, K.; Chiu, A.; more...
Clinical Lymphoma, Myeloma and Leukemia (2015)

Fulltext@MSK | Save

Clinical description of acute promyelocytic leukemia (APL) patients receiving all-trans retinoic acid (ATRA) who develop pseudotumor cerebri: Incidence, diagnosis, outcomes, and recommendations for management

Meeting Abstract

Coombs, C. C.; DeAngelis, L. M.; Feusner, J. H.; Tallman, M. S.
Clinical Lymphoma, Myeloma and Leukemia (2015)

Fulltext@MSK | Save

SF3B1 mutations constitute a novel therapeutic target in breast cancer

Meeting Abstract

Maguire, S.; Leonidou, A.; Wai, P.; Marchio, C.; Ng, C.; Sapino, A.; Vincent-Salomon, A.; Reis, J.; Weigelt, B.; Natrajan, R.
Cancer Research (2015)

Fulltext@MSK | Save

Circulating tumor DNA (ctDNA) analysis of PIK3CA and AKT1 mutations in patients enrolled onto the Phase 1b study of the PI3K inhibitor taselisib (GDC-0032) in solid malignancies

Meeting Abstract

Wilson, T. R.; Savage, H.; Aimi, J.; Jin, J.; Parmar, H.; Hsu, J.; Krop, I.; Saura, C.; Cervantes, A.; Sachdev, J.; more...
Cancer Research (2015)

Fulltext@MSK | Save

BRCA-mutated pancreas adenocarcinoma: Emerging therapeutic implications

Meeting Abstract

O'Reilly, E. M.
Cancer Research (2015)

Fulltext@MSK | Save